Prosecution Insights
Last updated: July 17, 2026
Application No. 18/716,031

PROCESS AND APPARATUS FOR THE MANUFACTURE OF SOLID MICROPARTICLES

Non-Final OA §103§112
Filed
Jun 03, 2024
Priority
Dec 03, 2021 — EU 21383090.4 +1 more
Examiner
MALEKZADEH, SEYED MASOUD
Art Unit
1754
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Sitec Pharmabio S L
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
630 granted / 939 resolved
+2.1% vs TC avg
Strong +32% interview lift
Without
With
+31.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
44 currently pending
Career history
987
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
76.7%
+36.7% vs TC avg
§102
14.0%
-26.0% vs TC avg
§112
3.2%
-36.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 939 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of claims 1-10, in the reply filed on 12/31/2025, is acknowledged. Claims 11-15 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected group of the invention, there being no allowable generic or linking claim. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation of “dense CO2” wherein the term “dense” is a relative term which renders the claim indefinite. The term “dense” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim 3 recites the limitation of “the form of an emulsion” in 2nd line. There is insufficient antecedent basis for this limitation in the claim because prior to the cited limitation, claim fails to define “a form of an emulsion”. Claim 8 recites the limitation of “the flows” in 1st line. There is insufficient antecedent basis for this limitation in the claim because even though prior to the cited limitation, claim 1 recites “a capillary or preatomized flow”. Neither claim 1 nor claim 8 recites “flows”. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or non-obviousness. Claim(s) 1-10 are rejected under 35 U.S.C. 103 as being unpatentable over Sievers et al. (US 6,630,121) in view of Chickering, III et al. (US 6,962,006). As to claim 1, Sievers et al. (US ‘121) disclose a process for the manufacture of solid microparticles (see the abstract) comprising: a) providing a fluid mixture comprising one or more molecules of interest (col. 24, claim 12 and col. 25, lines 13-15: a pharmaceutically active substance), one or more compounds selected from the group consisting of lipids, lipid-polymer compounds and polymers (claim 6: excipients which are often of polymeric nature like PEG or starch; col. 5, lines 47-60), and water (col. 4, lines 5-6); [AltContent: textbox (A nozzle (orifice of pressure restrictor 25))]b) mixing (col. 4, lines 10-12) the fluid mixture of step a) with supercritical or near supercritical carbon dioxide (CO2) (col. 7, lines 1-4) from a carbon dioxide reservoir 10 (col. 10, line 63) and supercritical nitrogen (col. 7, lines 10-21) from nitrogen reservoir 30 (col. 11, lines 26-27, and Fig. 1) to provide a dispersion of the fluid mixture of step a) and the supercritical nitrogen and the CO2 (according to page 17, line 19, in specification of the instant application, examples of “desiccating gas” is nitrogen, and also according to page 17, line 21, of the specification, the term “plasticizing gas” refers to CO2); [AltContent: arrow][AltContent: arrow][AltContent: textbox (Desiccating gas (N2) source )][AltContent: arrow][AltContent: textbox (Plasticizing gas (CO2) source)] PNG media_image1.png 254 417 media_image1.png Greyscale c) ejecting the dispersion obtained in step b) through a nozzle (orifice of pressure restrictor 25, col. 11, lines 15-18) thereby creating a capillary or pre-atomized flow (col. 7, line 66); and [AltContent: arrow][AltContent: arrow][AltContent: textbox (A gas flow to obtain the solid microparticles)] PNG media_image2.png 417 406 media_image2.png Greyscale d) contacting the capillary or pre-atomized flow obtained (in a drying tube 45, col. 11, lines 24-36, in step c) with a fluid of CO2 (the supercritical fluid is carbon dioxide CO2, col. 7, lines 1-4) to prepare fine dry particles (the gas may be chosen so as to react with the molecule of interest in the course of drying; col. 7, lines 22-29). Also, Sievers et al. (US ‘121) disclose the supercritical fluid is carbon dioxide (CO2) because carbon dioxide is endogenous and relatively non-toxic (col. 7, lines 1-4), however, fail to disclose, as to step d), the supercritical fluid CO2 is swirling or spiraling flow to obtain the solid microparticles, as claimed in claim 1. In the analogous art, Chickering, III et al. (US ‘006) disclose a method for making particles comprising: (a) spraying an emulsion, solution, or suspension, which comprises a solvent and a bulk material, through at least one atomizer and into a primary drying chamber having a drying gas inlet, a discharge outlet, and a drying gas flowing therethrough, to form droplets comprising the solvent and the bulk material, wherein the droplets are dispersed in the drying gas; (b) evaporating, in the primary drying chamber, at least a portion of the solvent into the drying gas to solidify the droplets and form particles dispersed in the drying gas, the particles dispersed in the drying gas being a feed-stream; and (c) flowing the particles of the feed-stream through a jet mill to deagglomerate or grind the particles, wherein the bulk [AltContent: textbox (A swirling or spiraling gas flow movement within the drying apparatus (20))]material comprises a pharmaceutical agent. (See col. 25, lines 7-22) [AltContent: arrow][AltContent: arrow] PNG media_image3.png 420 663 media_image3.png Greyscale Further, Chickering, III et al. (US ‘006) disclose a liquid feed and an atomization gas (e.g., air, nitrogen, etc.) are fed through an atomizer 14. The atomized droplets of solvent and bulk material are formed in the primary drying chamber 12. A drying gas is fed through an optional heater 18 and into a primary drying chamber 12. In the primary drying chamber, the droplets are dispersed in the drying gas, and at least a portion of the solvent is evaporated into the drying gas to solidify the droplets and form a feed a feed-stream of particles dispersed in the drying gas. This feed-stream then exits the primary drying chamber 12 through outlet 16 and enters (optional) secondary drying apparatus (20), which includes a coiled tube through which the feed-stream flows. (col. 6, lines 1-14) Also, Chickering, III et al. (US ‘006) teach the centrifugal force created causes the particles to be thrown toward the wall, and the drying gas falls downward along the wall and then spirals upward through the center when it reaches the bottom, producing a double vortex. (col. 8, lines 33-37) Therefore, as to claim 1, Chickering, III et al. (US ‘006) disclose a swirling or spiraling gas flow movement within the secondary drying apparatus (20) to obtain desired solid fine particles (col. 8, lines 33-37 and Fig. 2). It would have been obvious for one of ordinary skill, prior to the time of applicant’s invention, to modify the operation in step d), as taught by Sievers et al. (US ‘121), through providing a swirling or spiraling movement for the flow in order to improve the efficiency of evaporation of the solvent into the drying gas to solidify the droplets and forming particles dispersed in the drying gas, as suggested by Chickering, III et al. (US ‘006): col. 1, lines 60-64. As to claim 2, Chickering, III et al. (US ‘006) teach the one or more lipids, lipid-polymer compounds and polymers of the fluid mixture of step a) is selected of poly-oxylglycerides (col. 14, line 48, and col. 16, line 24) As to claim 3, Sievers et al. (US ‘121) disclose the fluid mixture of step a) is in the form of an emulsion (col. 6, line 45), microemulsion (col. 14, lines 21-22), suspension, solution, or concentrated solution (col. 14, lines 19-21) mixture. As to claim 4, Sievers et al. (US ‘121) teach the molecule of interest is hygroscopic. (col. 19, line 27) As to claim 5, Sievers et al. (US ‘121) disclose the desiccating gas (supercritical nitrogen; col. 7, lines 10-21) and/or plasticizing gas (supercritical carbon dioxide CO2) of step b) is selected from the group consisting of nitrogen, CO2 and a mixture thereof. According to page 17, line 19, in specification of the instant application, examples of “desiccating gas” is nitrogen, and also according to page 17, line 21, of the specification, the term “plasticizing gas” refers to CO2. Sievers et al. (US ‘121) does not disclose the desiccating gas and/or plasticizing gas of step b) is provided at a pressure of from 0.2 to 16 bar, as claimed in claim 6, or the expanding liquid or dense CO2 is provided at a pressure before expansion of from 15 to 70 bar However, Chickering, III et al. (US ‘006), as to claim 6, disclose the desiccating gas and/or plasticizing gas is provided at a pressure of from 0.2 to 16 bar (col. 10, lines 6-7: these gas pressures, preferably dry nitrogen, is between 0 and 10 bar, more preferably between 2 and 8 bar), or as to claim 7, Chickering, III et al. (US ‘006) disclose the expanding liquid or dense CO2 is provided at a pressure before expansion of from 15 to 70 bar. (col. 10, lines 6-7) It would have been obvious for one of ordinary skill, prior to the time of applicant’s invention, to modify the pressure of the desiccating gas and/or plasticizing gas in step b), as taught by Sievers et al. (US ‘121), so to be at a pressure of from 0.2 to 16 bar in order to efficiently control the particle production throughput through adjusting the pressure of desiccating gas and/or plasticizing gas, as suggested by Chickering, III et al. (US ‘006): col. 10, lines 7-10. It would have been obvious for one of ordinary skill, prior to the time of applicant’s invention, to modify the expanding liquid or dense CO2 in step d), as taught by Sievers et al. (US ‘121), so to be at a pressure of before expansion of from 15 to 70 bar in order to efficiently control the particle production throughput through adjusting the pressure of desiccating gas and/or plasticizing gas, as suggested by Chickering, III et al. (US ‘006): col. 10, lines 7-10. As to claim 8, Sievers et al. (US ‘121) disclose the flows that are contacted in step d) are ejected at an angle of from 0° to 90° with respect to each other. (col. 13, lines 66-67 and col. 14, lines 1-5: the angle of the conical tip may be varied from very acute to very sharp (from about 5 degrees from the plane of the body of the restrictor to about 89 degrees from the plane of the body of the restrictor) As to claim 9, Sievers et al. (US ‘121) teach the fluid mixture of step a) is provided at a temperature of from 4° C. to 250° C. (col. 17, lines 6-14), step b) is carried out at a temperature of from 20° C. to 250° C. (col. 17, lines 6-14), step c) is carried out at a temperature of from 20° C. to 250° C. (col. 15, lines 31-34), and/or step d) is carried out at a temperature of from −20° C. to +35° C (col. 17, lines 6-14). As to claim 10, Sievers et al. (US ‘121) disclose the process is performed continuous. (col. 15, lines 43-47) Relevant Prior Art The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Shekunov et al. (US 7,208,106) disclose a method of forming particles comprising: providing a solution comprising a solute dispersed or dissolved in a solvent; contacting the solution with a first compressed or liquefied gas at an initial temperature to form a mixture; expanding the mixture at a first temperature to form droplets; contacting the droplets with an extracting fluid at a second temperature at which the solvent is extracted from the droplets to form particles comprising the solute; and separating the particles from the extracting fluid and solvent. (see col. 11, last paragraph, and col. 12, first paragraph) Reverchon et al. (US 7,276,190) disclose a process for producing micro and/or nano particles of solids with a mean diameter ranging between 0.01 and 100 micrometers, the process comprising the steps of: solubilizing a solid in a liquid solvent or a mixture of liquid solvents, the liquid solvent or the mixture of liquid solvents having very low or zero solubility in carbon dioxide under conditions with temperature between 30 and 100.degree. C. and pressure between 50 and 240 bar; solubilizing a dense carbon dioxide in the liquid solvent or the mixture of liquid solvents, the dense carbon dioxide being compressed, liquid or supercritical, wherein solubilization takes place in a saturation chamber loaded with high surface packings at process conditions with temperature between 30 and 100.degree. C. and pressure between 50 and 240 bar; injecting a thus obtained solution through a thin wall injector into a precipitation vessel operated at pressures near atmospheric pressure; and recovering produced powders. (See col. 7, claim 1) Correspondence Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to SEYED MASOUD MALEKZADEH whose telephone number is (571)272-6215. The examiner can normally be reached M-F 8:30AM-5:00PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, SUSAN D. LEONG can be reached at (571)270-1487. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SEYED MASOUD MALEKZADEH/Primary Examiner Art Unit 1754 04/16/2026
Read full office action

Prosecution Timeline

Jun 03, 2024
Application Filed
Apr 21, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679024
DEVICES, SYSTEMS AND METHODS FOR PRINTING THREE-DIMENSIONAL OBJECTS
5y 11m to grant Granted Jul 14, 2026
Patent 12679034
APPARATUS AND METHOD FOR PRODUCING AN ARTICLE BY ADDITIVE MANUFACTURING
5y 9m to grant Granted Jul 14, 2026
Patent 12677838
FOOD PROCESSING DEVICE, COMPONENTRY, AND RELATED METHODS
2y 9m to grant Granted Jul 14, 2026
Patent 12667110
Porous Mould Drum For Poultry, Pork, Meat-Replacement and Vegetarian Food
2y 8m to grant Granted Jun 30, 2026
Patent 12654386
Pouch Curl Prevention Apparatus
3y 4m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
99%
With Interview (+31.9%)
3y 3m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 939 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month